Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Factors Cause Vasospasm After Aneurysmal Subarachnoid Hemorrhage
This study is currently recruiting participants.
Verified by National Taiwan University Hospital, September 2008
Sponsored by: National Taiwan University Hospital
Information provided by: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00745758
  Purpose

Extensive research has shown that the big event that leads to the initiation of vasospasm is the release of oxyhemoglobin (blood breakdown product).Depletion of NO synthase (19,20,21) was also noted after SAH.CSF is produced from choroid plexus in the ventricle. If the SAH is too dense, the blood in the subarachnoid space will not easy to be washed out.


Condition
Subarachnoid Hemorrhage
Vasospasm, Intracranial

U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: The Factors Cause Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Further study details as provided by National Taiwan University Hospital:

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

CSF


Estimated Enrollment: 20
Study Start Date: May 2008
Estimated Study Completion Date: September 2008
Detailed Description:

Cerebral vasospasm remains a significant source of morbidity and mortality in patients with subarachnoid hemorrhage (SAH) after an aneurysmal rupture. Despite being a significant source of morbidity and mortality, death and disability from vasospasm have declined from approximately 35% in the early 1970's, to between 15% and 20% in the 1980's to <10% in the 1990's(1,2,3,4).Extensive research has shown that the big event that leads to the initiation of vasospasm is the release of oxyhemoglobin (blood breakdown product)(1,12,13). This mechanism appears to be a multifactorial process that involves the generation of free radicals, lipid peroxidation and activation of protein kinase C as well as phospholipase C and A2 with resultant accumulation of diacylglycerol and the release of endothelin-1(14,15,16,17,18). On the other hand, depletion of NO synthase (19,20,21) was also noted after SAH. Previous reports showed that shunting of CSF through a lumbar drain after an SAH markedly reduces the risk of clinically evident vasospasm and its sequelae, shortens hospital stay, and improves outcome. Its beneficial effects are probably mediated through the removal of spasmogens that exist in the CSF(22). In our preliminary data, we have demonstrated a case with severe vasospasm, CSF was collected both from EVD and lumbar drain. The ADMA level and amount of Nitrate was well correlate with vasospasm and the level was much higher in lumbar drain then EVD. So, we will compared the CSF from EVD and lumbar puncture to see which factor is correlate with vasospasm.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patient of spontaneous SAH

Criteria

Inclusion Criteria:

  • Aneurysmal rupture with SAH

Exclusion Criteria:

  • Bleeding tendency,
  • Large ICH with impending herniation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00745758

Contacts
Contact: Kuo-Chuan Wang, MD 886-223123456 ext 5077 wang081466@yahoo.com.tw

Locations
Taiwan
devision of neurosurgery, National taiwan university hospital Recruiting
Taipei, Taiwan, 112
Contact: Kuo-Chuan Wang, MD     886223123456     wang081466@yahoo.com.tw    
Principal Investigator: Kuo-Chuan Wang, MD            
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Kuo-Chuan Wang, MD NTUH
  More Information

Responsible Party: Devision of neurosurgery ( Kuo-Chuan Wang )
Study ID Numbers: 200803080R
Study First Received: August 31, 2008
Last Updated: September 2, 2008
ClinicalTrials.gov Identifier: NCT00745758  
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
SAH, vasospasm, ADMA

Study placed in the following topic categories:
Vascular Diseases
Subarachnoid Hemorrhage
Central Nervous System Diseases
Intracranial Hemorrhages
Brain Diseases
Hemorrhage
Cerebrovascular Disorders
Vasospasm, Intracranial

Additional relevant MeSH terms:
Pathologic Processes
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009